Axitinib, cabozantinib, or everolimus in the treatment of prior sunitinib-treated patients with metastatic renal cell carcinoma: results of matching-adjusted indirect comparison analyses

BACKGROUND: In the absence of head-to-head trials comparing axitinib with cabozantinib or everolimus, the aim of this study was to conduct an indirect comparison of their relative efficacy in patients with metastatic renal cell carcinoma (mRCC), using data from the AXIS and METEOR trials. METHODS: P...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Proskorovsky, Irina, Benedict, Agnes, Negrier, Sylvie, Bargo, Danielle, Sandin, Rickard, Ramaswamy, Krishnan, Desai, Jigar, Cappelleri, Joseph C., Larkin, James
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6300002/
https://ncbi.nlm.nih.gov/pubmed/30567533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-5157-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados